Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · IEX Real-Time Price · USD
2.490
-0.220 (-8.12%)
At close: Jul 2, 2024, 4:00 PM
2.470
-0.020 (-0.80%)
After-hours: Jul 2, 2024, 7:08 PM EDT
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $64.57 million as of July 2, 2024. Its market cap has increased by 15.52% in one year.
Market Cap
64.57M
Enterprise Value
59.43M
1-Year Change
15.52%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $64.57M, a decrease of -60.35%. That is a compound annual growth rate of -25.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 69.50M | 12.10% |
| Dec 29, 2023 | 62.00M | -0.16% |
| Dec 30, 2022 | 62.10M | -56.75% |
| Dec 31, 2021 | 143.60M | -11.83% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CASI Pharmaceuticals | 73.71M |
| Silver Spike Investment | 73.46M |
| Eagle Pharmaceuticals | 72.73M |
| Aurora Cannabis | 72.66M |
| Prenetics Global | 72.33M |
| Anixa Biosciences | 70.73M |
| MediciNova | 70.63M |
| Milestone Pharmaceuticals | 70.30M |